Bleeding+ | Bleeding− | p | |
Age | 62.21 ± 12.68 | 62.78 ± 11.92 | 0.78 |
Male (%) | 56.40% | 60.40% | 0.37 |
Diabetes Mellitus (%) | 33% | 39.40% | 0.71 |
Hypertension (%) | 71.80% | 81.30% | 0.11 |
Smoke (%) | 43.60% | 41.40% | 0.46 |
FH of CAD (%) | 12.80% | 12.40% | 0.55 |
Dyislipidemia (%) | 35.90% | 47.70% | 0.1 |
Stable angina (%) | 5.10% | 13.00% | 0.34 |
Heart failure (%) | 5.10% | 7.70% | 0.56 |
Previous AMI (%) | 43.60% | 37.70% | 0.29 |
Previous CABG (%) | 10.30% | 16.00% | 0.24 |
Previous PCI (%) | 25.60% | 25.40% | 0.55 |
SAP (mmHg) | 133.41 ± 30.94 | 132.74 ± 28.51 | 0.89 |
Hb (g/dL) (median) | 13.1 ± 2.69 | 13.84 ± 1.88 | 0.02 |
Cr (mg/dL) (median) | 1.51 ± 1.57 | 1.29 ± 0.83 | 0.14 |
Troponin (higher/median) (ng/dL) | 5.46 ± 9.96 | 6.31 ± 34.95 | 0.88 |
EF (%) (median) | 47.97 ± 18.74 | 39.52 ± 24.42 | 0.04 |
AAS (%) | 94.90% | 95.90% | 0.9 |
B-blockerr (%) | 61.50% | 69% | 0.6 |
Enoxaparin (%) | 56.40% | 71.60% | 0.03 |
GPI IIb/IIIa (%) | 17.90% | 11.80% | 0.26 |
Clopidogrel (%) | 82.10% | 57.80% | 0.003 |
ACE inhibitor (%) | 38.50% | 50.10% | 0.11 |
Statin (%) | 69.20% | 81.90% | 0.04 |